Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucilla Parnetti

Showing results (261-270 of 283) with videos related to

Pageof 29
Sort By:
Neurobiology of Aging|June 22, 2015
Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory studyNiels Kruse, Staffan Persson, Daniel Alcolea, et al.
Magnetic Resonance Imaging|November 21, 2020
Accuracy and reproducibility of automated white matter hyperintensities segmentation with lesion segmentation tool: A European multi-site 3T studyFederica Ribaldi, Daniele Altomare, Jorge Jovicich, et al.
Journal of Alzheimer'S Disease : JAD|January 7, 2017
Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular VolumesLinda J C van Waalwijk van Doorn, Juan D Gispert, H Bea Kuiperij, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 8, 2021
Characteristics of subjective cognitive decline associated with amyloid positivityOlin Janssen, Willemijn J Jansen, Stephanie J B Vos, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|October 28, 2017
Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological PsychiatryPiotr Lewczuk, Peter Riederer, Sid E O'Bryant, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 23, 2025
Clinical use and reporting of neurofilament quantification in neurological disorders: A global overviewConstance Delaby, Aurélie Ladang, Jose Martinez-Yriarte, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersConstance Delaby, Aurélie Ladang, Jose Yriarte, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 22, 2021
Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overviewConstance Delaby, Charlotte E Teunissen, Kaj Blennow, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 26, 2011
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkersNiklas Mattsson, Ulf Andreasson, Staffan Persson, et al.
JAMA Network Open|May 17, 2023
Genetic Associations Between Modifiable Risk Factors and Alzheimer Disease, Jiao Luo, Jesper Qvist Thomassen, et al.
Pageof 29

Showing results (261-270 of 283) with videos related to

Sort By:
Pageof 29
Neurobiology of Aging|June 22, 2015
Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory studyNiels Kruse, Staffan Persson, Daniel Alcolea, et al.
Magnetic Resonance Imaging|November 21, 2020
Accuracy and reproducibility of automated white matter hyperintensities segmentation with lesion segmentation tool: A European multi-site 3T studyFederica Ribaldi, Daniele Altomare, Jorge Jovicich, et al.
Journal of Alzheimer'S Disease : JAD|January 7, 2017
Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular VolumesLinda J C van Waalwijk van Doorn, Juan D Gispert, H Bea Kuiperij, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 8, 2021
Characteristics of subjective cognitive decline associated with amyloid positivityOlin Janssen, Willemijn J Jansen, Stephanie J B Vos, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|October 28, 2017
Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological PsychiatryPiotr Lewczuk, Peter Riederer, Sid E O'Bryant, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 23, 2025
Clinical use and reporting of neurofilament quantification in neurological disorders: A global overviewConstance Delaby, Aurélie Ladang, Jose Martinez-Yriarte, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersConstance Delaby, Aurélie Ladang, Jose Yriarte, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 22, 2021
Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overviewConstance Delaby, Charlotte E Teunissen, Kaj Blennow, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 26, 2011
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkersNiklas Mattsson, Ulf Andreasson, Staffan Persson, et al.
JAMA Network Open|May 17, 2023
Genetic Associations Between Modifiable Risk Factors and Alzheimer Disease, Jiao Luo, Jesper Qvist Thomassen, et al.
Pageof 29